» Articles » PMID: 17205349

Sacral Chordoma: a Diagnosis Not to Be Sat On?

Overview
Journal Int Orthop
Specialty Orthopedics
Date 2007 Jan 6
PMID 17205349
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Sacral chordomas are rare, slow-growing tumours that are amenable to surgery, but unfortunately often diagnosed late. The aim of the study was to identify presenting symptoms, which may aid diagnosis and reduce the treatment time. Forty-four patients were identified with sacral chordoma between 1989 and 2006. Clinical and pathological records were reviewed retrospectively to elicit the symptoms recorded prior to diagnosis, duration of symptoms, surgical treatment, size of tumour and survival. Eleven patients were excluded, leaving 33 patients in the study group. Thirty-one patients had chordomas arising from the sacrum and two patients from the coccyx. The mean duration of symptoms prior to diagnosis was 120 weeks (2.3 years), with a median of length of 104 weeks (two years) and range of 26 to 416 weeks (0.5 to eight years). The mean maximum tumour size at resection was 8.3 cm, with a mean volume of 614 cm(3) (range 9-2,113 cm(3)). Pain, typically dull and worse with sitting, was the most common presenting symptom in 85% of patients. The classic symptoms of cauda equina (saddle anaesthesia, bladder or bowel dysfunction) occurred in 70% patients (23 patients). Sacral chordoma should be considered in cases of back pain with coccydynia, especially with neurological symptoms.

Citing Articles

Three-dimensional virtual reality-assisted surgical planning for neuronavigated sacrectomy of a chordoma: a technical note.

Paun L, Lave A, Molliqaj G, Haemmerli J, Oranges C, Dominguez D Int Orthop. 2024; 48(11):2931-2939.

PMID: 39242394 DOI: 10.1007/s00264-024-06286-2.


Coccygeal tumours unveiled: a retrospective cohort analysis from a tertiary referral centre.

Gavvala S, Saad A, Shirodkar K, Ariyaratne S, Nischal N, Kurisunkal V Br J Radiol. 2024; 97(1162):1636-1644.

PMID: 39137133 PMC: 11417372. DOI: 10.1093/bjr/tqae148.


Animal model considerations for chordoma research: reproducing the tumor microenvironment with humanized mice.

Campilan B, Schroeder C, Sagaityte E, Arditi J, Leary O, Ziya L Gokaslan Front Oncol. 2024; 14:1330254.

PMID: 38544830 PMC: 10965562. DOI: 10.3389/fonc.2024.1330254.


Sacral chordoma: an unusual cause of neurogenic bladder - a case report.

Jelleli N, Mnasser A, Sakly A, Slama M, Fouli S, Chouaya I Ann Med Surg (Lond). 2023; 85(1):41-45.

PMID: 36742113 PMC: 9893423. DOI: 10.1097/MS9.0000000000000209.


Left to themselves: Time to target chronic pain in childhood rare diseases.

Sieberg C, Lebel A, Silliman E, Holmes S, Borsook D, Elman I Neurosci Biobehav Rev. 2021; 126:276-288.

PMID: 33774086 PMC: 8738995. DOI: 10.1016/j.neubiorev.2021.03.008.


References
1.
McMaster M, Goldstein A, Bromley C, Ishibe N, Parry D . Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001; 12(1):1-11. DOI: 10.1023/a:1008947301735. View

2.
Koes B, van Tulder M, Thomas S . Diagnosis and treatment of low back pain. BMJ. 2006; 332(7555):1430-4. PMC: 1479671. DOI: 10.1136/bmj.332.7555.1430. View

3.
Baratti D, Gronchi A, Pennacchioli E, Lozza L, Colecchia M, Fiore M . Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol. 2003; 10(3):291-6. DOI: 10.1245/aso.2003.06.002. View